✦ LIBER ✦

The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon

✍ Scribed by John F Beltrame; Stuart P Turner; Sue L Leslie; Patty Solomon; Saul B Freedman; John D Horowitz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mibefradil accelerates angiographic coro

✍ Stuart P. Turner; John F. Beltrame; Michael B. Taylor; John D. Horowitz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Persistence of the coronary slow flow ph

✍ John F. Beltrame; Stuart P. Turner; John D. Horowitz 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 25 KB

Coronary hemodynamic and metabolic studi

✍ John F Beltrame; Sananand B Limaye; Ronald D Wuttke; John D Horowitz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 133 KB

The effect of verapamil and nitroglyceri

✍ SHUFU CHANG; JUYING QIAN; JIANYING MA; JUNBO GE 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

THE SLOW CORONARY FLOW PHENOMENON IS NOT

✍ Caiati, Carlo; Lepera, Mario; Santoro, Daniela; Primitivo, Stefano Giuseppe; Lac 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Beneficial effects of mibefradil in the

✍ John F. Beltrame; Stuart P. Turner; Susan Leslie; Patty Solomon; Saul B. Freedma 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB